Novartis is poised to make one of its largest takeover deals in its history after agreeing to buy RNA specialist Avidity ...

AstraZeneca has breached the UK pharma industry's code of practice with a claim on its website for asthma drug Symbicort, ...

The Nubeqa (darolutamide) regimen can be used to treat adult patients with advanced HSPC if docetaxel, a chemotherapy agent, ...

The company ended the first half of this year with €3.1 billion ($3.6 billion) in cash reserves, and is due to report its ...

As someone with a sound scientific background, immersed in the technical side of this work, I’ve seen firsthand how the field ...

GSK and Spero Therapeutics' oral cabapenem, tebipenem HBr, has become the first antibiotic in the class to show efficacy in a ...

Johnny Cheng, currently CFO of HUTCHMED, has been named acting CEO following the departure of Dr Weiguo Su due to health ...

Akeso and Summit Therapeutics have shared the full data from the HARMONi-6 trial of PD-1xVEGF bispecific ivonescimab as a ...

Patient safety is a mindset that begins on day one and grows with every child. It is not confined to hospitals, it extends ...

Ipsen has reached an agreement to buy fellow French firm ImCheck Therapeutics in a deal that could be worth up to €1 billion ...

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once ...